Kesava R. Mannur

Kesava R. Mannur

Auto-generated profile, based on publicly available information

Kesava R. Mannur

Bariatric Surgery Department, Homerton University Hospital, Homerton Row, London, E9 6SR, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Gastrointestinal Endoscopy
Verified
Journal Article
Open access
PDF file
AFAnnette Fritscher-Ravens
Annette Fritscher-Ravens
JHJochen Hampe
Jochen Hampe
PGPhillippe Grange
Phillippe Grange
CHChristopher Holland
Christopher Holland
FOFemi Olagbeye
Femi Olagbeye
KMKesava Mannur
Kesava Mannur
Esophageal full-thickness wall repair is an important but unsolved issue in endoscopy. It is unknown how well endoscopic clip closure (ECC) and endoscopic closure with suturing (ECS) perform compared with the criterion standard of thoracoscopic closure (TC). Comparison of technical success, feasibility, long-term patency, complications, and histological quality of the different closure techniques (ECC, ECS, TC) for esophageal perforations. Comparative animal study. Approved animal facility. Eighteen pigs. Eighteen pigs were randomized, 6 each into 3 groups (ECC, ECS, TC). After endoscopic wall incision and mediastinoscopy, closure was performed by using 1 of the 3 techniques. After 8 to 12 weeks, pre-euthanasia endoscopic, necropsy, histological, and morphometric analyses were performed. Long-term survival and histological quality of the repair. The closure of the esophageal incisions was successful in all pigs. On days 2 and 6, 1 animal died of mediastinitis, 1 in the ECS group because of reflux of gastric contents into the mediastinum before the repair and 1 in the TC group because of leakage of the sutured closure (P = 1.0). No strictures were seen on prenecropsy endoscopy. At necropsy, 1 mediastinal abscess was found in an ECS animal (P = 1.0). Minor complications included periesophageal adhesions and reactive lymph nodes in 3 of 6 (ECC group) and 5 of 6 (TC and ECS groups). Histology showed muscle layer defects up to 12 mm in width and 21 mm in length, with a trend toward smaller defect size of width and length in the ECS group of animals. Animal study of limited size. Overall, ECS and ECC performed similarly to TC. ECS showed the smallest histological defects in the long-term repair.

20 April 2014 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
JBJ. Broad
J. Broad
AGAgnieszka Góralczyk
Agnieszka Góralczyk
KMK. Mannur
K. Mannur
GDG. E. Dukes
G. E. Dukes
GSGareth J Sanger
Gareth J Sanger

1 December 1992 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
BPB V Palmer
B V Palmer
KMK R Mannur
K R Mannur
WRW B Ross
W B Ross

1 March 2012 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
SMSamrat Mukherjee
Samrat Mukherjee
KDKalpana Devalia
Kalpana Devalia
MRMehtab G. Rahman
Mehtab G. Rahman
KMKesava R. Mannur
Kesava R. Mannur

21 January 2009 in Endoscopy
Verified
Journal Article
Closed access
AFA. Fritscher-Ravens
A. Fritscher-Ravens
AGA. Ghanbari
A. Ghanbari
CHC. Holland
C. Holland
FOF. Olagbeye
F. Olagbeye
KHK. G. Hardeler
K. G. Hardeler
KMK. Mannur
K. Mannur
Background and study aim: Significant hemorrhage is a likely complication during natural orifice transluminal endoscopic surgery (NOTES) procedures. We tested three different prototype devices (involving endoscopic suturing, monopolar forceps, and forced argon plasma coagulation [FAPC]) for treatment of acute bleeding in a survival animal model. Method: Using transgastric access (TGA) or transvaginal access (TVA), the endoscope was introduced into the peritoneal cavity and the first side-branch of the gastroepiploic artery (1aGE) was cut before the different hemostatic methods were applied. Results: Sutures could not be placed quickly enough before vision was inhibited. With monopolar forceps via TGA, the time to control bleeding was 10 – 140 s (mean 58 ± 41 s) and with TVA it was 25 – 115 s (mean 57 ± 26 s) (P = 0.54). It was not possible to stop the bleeding in 4/6 animals with TGA access and in 3/6 with TVA, and FAPC was needed to entirely stop it, taking a further 10 – 280 s (TGA mean 126 ± 90 s, 34 – 242 s; TVA mean 152 ± 61 s; P = 0.42). Using FAPC with TGA took 4 – 72 s (mean 28 ± 20 s) to stop the bleeding, and 16 – 41 s (mean 24 ± 9.4 s) with TVA (P = 0.64). As the FAPC technique was relatively so much better, additional treatment of bleeding from the main gastroepiploic artery (aGe) was added in four cases for each method of access; this was successful but took significantly longer, with TGA at 10 – 260 s and with TVA at 30 – 172 s (means 98 ± 82, 117 ± 54 s, respectively; not significant). Conclusion: Regarding the three methods tested, the new prototype FAPC device allowed hemostasis of notable bleeding from a major vessel even more quickly than forceps coagulation of a bleeding side branch. More studies are needed to further explore this potentially very valuable tool.

1 February 2016 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
JBJohn Broad
John Broad
NTNobuyuki Takahashi
Nobuyuki Takahashi
MTMasaomi Tajimi
Masaomi Tajimi
MSMasaki Sudo
Masaki Sudo
AGAdam Góralczyk
Adam Góralczyk
GSGareth J Sanger
Gareth J Sanger
The aim was to characterise RQ-00201894, a novel non-macrolide motilin agonist, using human recombinant receptors and then investigate its ability to facilitate cholinergic activity in human stomach. A reporter gene assay assessed motilin receptor function. Selectivity of action was determined using a panel of different receptors, ion channels, transporters and enzymes. Cholinergically-mediated muscle contractions were evoked by electrical field stimulation (EFS) of human gastric antrum. The results showed that RQ-00201894, motilin and erythromycin acted as full motilin receptor agonists (EC50: 0.20, 0.11, 69 nM, respectively). In this function, RQ-00201894 had >90-fold selectivity of action over its ability to activate the human ghrelin receptor (EC50 19 nM) and greater selectivity over all other receptors/mechanisms tested. In human stomach RQ-00201894 0.1-30 μM concentration-dependently increased EFS-evoked contractions (up to 1209%; pEC50 6.0). At 0.1-10 μM this activity was usually prolonged. At higher concentrations (3-30 μM) RQ-00201894 also caused a short-lasting muscle contraction, temporally disconnected from the increase in EFS-evoked contractions. RQ-00201894 10 μM did not consistently affect submaximal contractions evoked by carbachol. In conclusion, RQ-00201894 potently and selectively activates the motilin receptor and causes long-lasting facilitation of cholinergic activity in human stomach, an activity thought to correlate with an ability to increase gastric emptying.